Form 4: Oncology Institute COO Jeremy Castle Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jeremy Castle, Chief Operating Officer of Oncology Institute, sold shares of common stock on May 21, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 21, 2025, Jeremy Castle, the Chief Operating Officer of Oncology Institute, sold 5,636 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- The shares were sold at a price of $2.675 per share.
- Following the transaction, Castle directly owns 247,031 shares of Oncology Institute common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction for tax purposes and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when RSUs vest.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a small percentage of the outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of stock sale transaction |
| 05/22/2025 | Date of signature on the Form 4 filing |
Keywords
Oncology Institute, Jeremy Castle, stock sale, Form 4, COO, RSU, tax withholding, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.